Earnings ·
Neogen reports Q1 FY2027 revenue of $222.8M, raises full-year guidance
NEOGNeogen Corp
Neogen Corporation reported first-quarter fiscal 2027 results with total revenues of $222.8 million, a 6.5% increase from the prior year period. The company posted a net loss of $11.9 million, or $(0.05) per diluted share, compared to net income of $36.3 million in the previous quarter. Adjusted net income rose to $17.5 million, or $0.08 per diluted share, driven by higher EBITDA and lower interest expenses. Gross margin improved to 47.4% from 45.4%, while adjusted EBITDA reached $41.6 million with an 18.7% margin. Management raised full-year fiscal 2027 financial guidance, now expecting revenue between $885 million and $890 million and adjusted EBITDA between $181 million and $183 million. Neogen operates in the food safety and animal health sectors, providing detection products, diagnostics, and related services.